Anda belum login :: 01 Feb 2023 16:28 WIB
ArtikelEvaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial  
Oleh: Harada, Tasuku ; Momoeda, Mikio ; Terakawa, Naoki ; Taketani, Yuji
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 95 no. 06 (May 2011), page 1928-1931.
Topik: Oral contraceptives; primary dysmenorrhea; placebo-controlled randomized trial
  • Perpustakaan FK
    • Nomor Panggil: F02.K.2011.03
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelObjective To evaluate the efficacy and safety of low-dose oral contraceptives (IKH-01; 0.035 mg ethinyl estradiol and 1 mg norethisterone) for patients with primary dysmenorrhea. Design Placebo-controlled, double-blind, randomized trial. Setting Clinical trial sites in Japan. Patient(s) One hundred fifteen patients with primary dysmenorrhea. Intervention(s) Patients randomly assigned to receive IKH-01 or placebo for four cycles. Main Outcome Measure(s) Total dysmenorrhea score, verbal rating scale defining pain according to limited ability to work and need for analgesics, and visual analog scale (VAS). Result(s) Reduction in total dysmenorrhea score and VAS before and after treatment was significantly higher in the IKH-01 group than in the placebo group. Total dysmenorrhea score and VAS in the IKH-01 group significantly decreased from cycles 2 to 5. Overall incidence of adverse events was significantly higher in the IKH-01 group. Incidence decreased over time in the IKH-01 group; it was invariable in the placebo group. No serious adverse events occurred. Conclusion(s) IKH-01 could be used as a single agent or in combination with analgesics for treatment of primary dysmenorrhea.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Process time: 0.046875 second(s)